Literature DB >> 8740983

Evolution of the neuropathology of Alzheimer's disease.

H Braak1, E Braak.   

Abstract

Our knowledge of the etiology and pathogenesis of Alzheimer's disease is limited. The most conspicuous changes seen in the brain are deposits of insoluble proteins in both extracellular and intraneuronal locations. The extracellular deposits consist primarily of a specific A4 amyloid protein. The significance of these deposits remains to be determined, as they are often found in the cerebral cortex of non-demented elderly persons. More telling is the gradual accumulation of insoluble fibrous material within some neurons that consists mainly of abnormally phosphorylated tau protein. Six stages of increasingly severe cortical destruction can be distinguished. Stages I and II are characterized by neurofibrillary changes that are largely confined to the transentorhinal region, whereas stages III and IV are marked by severe involvement of both the entorhinal and transentorhinal regions. Isocortical destruction occurs during stages V and VI. This progression in cortical pathology correlates with the gradual worsening of clinical symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8740983     DOI: 10.1111/j.1600-0404.1996.tb05866.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  217 in total

1.  A sparse structure learning algorithm for Gaussian Bayesian Network identification from high-dimensional data.

Authors:  Shuai Huang; Jing Li; Jieping Ye; Adam Fleisher; Kewei Chen; Teresa Wu; Eric Reiman
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2013-06       Impact factor: 6.226

2.  Reduced benefit from mnemonic strategies in early-stage Alzheimer's disease: a brief testing-the-limits paradigm for clinical practice.

Authors:  Ingo Uttner; Niklas Schurig; Christine A F von Arnim; Christian Lange-Asschenfeldt; Hayrettin Tumani; Matthias W Riepe
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

3.  Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.

Authors:  Michelle M Mielke; Ozioma C Okonkwo; Kenichi Oishi; Susumu Mori; Sarah Tighe; Michael I Miller; Can Ceritoglu; Timothy Brown; Marilyn Albert; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012       Impact factor: 21.566

Review 4.  Imaging Alzheimer's disease.

Authors:  Scott A Small
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

5.  Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging.

Authors:  Scott A Small; Monica K Chawla; Michael Buonocore; Peter R Rapp; Carol A Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 6.  Combining brain imaging with microarray: isolating molecules underlying the physiologic disorders of the brain.

Authors:  Aimee Pierce; Scott A Small
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

7.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

8.  Yes/no versus forced-choice recognition memory in mild cognitive impairment and Alzheimer's disease: patterns of impairment and associations with dementia severity.

Authors:  Lindsay R Clark; Nikki H Stricker; David J Libon; Lisa Delano-Wood; David P Salmon; Dean C Delis; Mark W Bondi
Journal:  Clin Neuropsychol       Date:  2012-10-02       Impact factor: 3.535

9.  Adjustment for selection bias in observational studies with application to the analysis of autopsy data.

Authors:  S Haneuse; J Schildcrout; P Crane; J Sonnen; J Breitner; E Larson
Journal:  Neuroepidemiology       Date:  2009-01-29       Impact factor: 3.282

Review 10.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.